Order Book analysis by شرکت داروسازی تهران شیمی about Stock هجرت: Buy recommendation (8/13/2025)
https://sahmeto.com/message/3707472
شرکت داروسازی تهران شیمی
Rank: 8332
Analytical Power:
0.1
Tehran Pharmaceutical Chemistry Company purchased 4427.465 million shares of Hijra on 14/05/22 and currently holds 23.241 % of Hijra's shares in its equity portfolio.
Translated from: Farsi
Show Original Message
Signal Type: Buy
Source Message:
Price at Publish Time:
32,900